Anne Pritam


Anne is a partner in the firm’s employment practice. She has advised clients in the life sciences sector for many years, and understands well the HR challenges of this innovative, highly regulated environment, employing some of the world’s brightest scientists.  
Anne helps clients with the practical implications of employment law. Her advice always takes account of clients’ unique workplace cultures, and focuses on achieving positive outcomes. Anne has been the trusted adviser to many of her clients for over 10 years.

Her practice encompasses the drafting of employment and consultancy contracts and policies, HR advisory work, litigation in the High Court (e.g. to protect confidential information, enforce restrictions or defend bonus claims); Employment and Employment Appeal Tribunals (defending employee statutory claims); advising on transactional due diligence, warranties and indemnities, and procedures under the transfer of undertakings legislation.

She often advises on employee issues alongside other specialists in the life sciences team (e.g. in relation to data protection, agency terms and regulatory investigations).

She also heads the firm’s UK-inbound immigration practice.

Anne’s life sciences experience includes advising:

  • Japanese HQ’d pharmaceutical group EISAI on all its UK employment and HR related issues.
  • Incyte Pharmaceuticals (USA/Switzerland) on UK employment and HR matters.
  • Swiss-based bluebird bio on employment matters in the UK.
  • Nanostring Technologies (USA) on the employment implications of the grant of an exclusive licence of nCounter diagnostic assets and rights in the UK, Europe and Israel and HR procedural requirements.
  • Speciality Pharmaceutical Company on a sensitive procedural matter.
  • Multiple international life sciences companies in relation to numerous commercial and corporate transactions, and the protection of confidential business information including Gilead Sciences, Oncimmune, BTG plc, UCB and Piramal Healthcare.

She has a towering intellect and sees both the detailed and high-level view of the case.

Chambers UK 2021